Serological responses to three doses of SARS-CoV-2 vaccination in inflammatory bowel disease
Author:
Funder
Leona M. and Harry B. Helmsley Charitable Trust
Public Health Agency of Canada
Canadian Institutes of Health Research
Publisher
BMJ
Subject
Gastroenterology
Reference9 articles.
1. Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD
2. Lin S , Kennedy NA , Saifuddin A , et al . Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab. Nat Commun 2022;13:1379.doi:10.1038/s41467-022-28517-z
3. Serologic response to coronavirus disease 2019 (COVID-19) vaccination in patients with immune-mediated inflammatory diseases: a systematic review and meta-analysis;Sakuraba;Gastroenterology,2022
4. Jena A , James D , Singh AK , et al . Effectiveness and durability of COVID-19 vaccination in 9447 patients with IBD: a systematic review and meta-analysis. Clinical Gastroenterology and Hepatology 2022;21.doi:10.1016/j.cgh.2022.02.030
5. Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: COVID-19 Vaccines—Biology, Current Evidence and Recommendations
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent advances in carbon quantum dots for antibiotics detection;Reviews in Inorganic Chemistry;2024-06-28
2. When Should I Get My Next COVID-19 Vaccine? Data From the Surveillance of Responses to COVID-19 Vaccines in Systemic Immune-Mediated Inflammatory Diseases (SUCCEED) Study;The Journal of Rheumatology;2024-04-15
3. Higher and Sustained Cell-Mediated Immune Responses after Three Doses of mRNA COVID-19 Vaccine In Patients with Inflammatory Bowel Disease on Anti-TNF Therapy;Clinical and Translational Gastroenterology;2024-02-13
4. Immunization of children with inflammatory bowel disease against SARS-CoV-19 infection: A prospective single centre cohort study;Vaccine: X;2023-12
5. The 2023 Impact of Inflammatory Bowel Disease in Canada: COVID-19 and IBD;Journal of the Canadian Association of Gastroenterology;2023-09-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3